Translational Research Office (TRO)


The Biologics TIN Seminar showcases brilliant science and makes the support for ECRs more accessible

26 May 2023

On 23 May 2023, close to 30 participants gathered at the UCL Biologics TIN (Therapeutic Innovation Networks) Seminar to explore biologic therapies, translational research, and the support available to ECRs.

In the photo: Prof Paul Dalby - Biologics TIN Chair, Dept of Biochemical Engineering

In the photo: Prof Paul Dalby - Biologics TIN Chair, Dept of Biochemical Engineering

The event was a great opportunity to demonstrate how Biologics have added major and growing therapeutic options for the treatment of many diseases. We had fantastic examples of how RNA, antisense oligonucleotide and monoclonal antibody therapies could be applied to address high medical needs and revolutionise patients’ lives.

At the seminar, Prof Paul Dalby from the Department of Biochemical Engineering, Chair of Biologics TIN, inspired the audience with his talk on "Biochemical Engineering: Optimising Product and Process for Biologics Manufacturing." Additionally, Prof. Ahad Rahim from the School of Pharmacy shared invaluable experiences by discussing the Rollercoaster Ride of Advancing Biologics along the Translational Pipeline.

The highlight of the event was the celebration of the great work of Early Career Researchers (ECRs) with projects across a wide range of subjects, fostering knowledge exchange and inviting discussions.

At the end of the session, the TIN hosted a lively panel discussion on support available at UCL to facilitate and accelerate translational research. ECRs encounter numerous challenges, including securing funding, publishing their work, and advancing their careers. When it comes to translational research, the process to bring research discoveries from “bench to bedside” can leave ECRs feeling uncertain about how or where to begin.

With this in mind, our panel offered the event participants invaluable insights into various topics, such as understanding UCL's research support ecosystem, funding opportunities, training support, collaborations within and beyond UCL, intellectual property (IP) and technology transfer, and practical career development tips for ECRs.

Round Table Discussion

By organising this seminar, the TIN strives to foster knowledge sharing and facilitate connections among ECRs interested in biologic therapies and translational research. We aim to make the available support more accessible to ECRs and encourage collaborations.

We extend our gratitude to the speakers and all attendees for their enthusiastic participation, and we hope that these discussions provide strong leads for ongoing interactions.


  • Prof. Paul Dalby - TIN Chair, Department of Biochemical Engineering
  • Prof. Ahad Rahim, School of Pharmacy
  • Dr Giulia De Rossi, Institute of Ophthalmology
  • Dr Jinhong Meng, GOS ICH Genetics and Genomic Medicine
  • Dr Reddy Sreekanth Vootukuri, GOS ICH Genetics and Genomic Medicine
  • Dr Christy Hung, GOS ICH Department of Developmental Biology & Cancer
  • Dr Thomas McDonnell, Division of Medicine & Dept Biochemical Engineering
  • Dr Sara Aguti, Queen Square Institute of Neurology
  • Dr George Firth, GOS ICH Genetics and Genomic Medicine
  • Dr Asha Recino - Research Networks & Partnerships Manager, UCL Translational Research Office

Round Table Discussion Panel:

Interested to join our future events?

  • Subscribe to our newsletter and you would automatically become a member of UCL TINs (Therapeutic Innovation Networks) and be the first to receive our event invitations

  • Follow us on social media (LinkedInTwitter) and stay tuned to our news and updates.

Exclusive capabilities resource for you:

TRO has created an online, internal portal (UCL sign-in required) to showcase the breadth of biomedical expertise at UCL and our partner hospitals, aiming to facilitate multidisciplinary collaborations and capabilities mapping. 

  • Input your profile to get your capabilities visible across UCL experts and potentially external partners facilitated by TRO, leading to collaboration and funding opportunities.